89 related articles for article (PubMed ID: 32332599)
1. Association between polymorphisms of epidermal growth factor 61 and susceptibility of lung cancer: A meta-analysis.
Chen Q; Zheng Y; Wu B; Chen X; Ge P; Wang P
Medicine (Baltimore); 2020 Apr; 99(17):e19456. PubMed ID: 32332599
[TBL] [Abstract][Full Text] [Related]
2. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma.
Tao Y; Liang G
Tumour Biol; 2014 Jan; 35(1):369-77. PubMed ID: 23963773
[TBL] [Abstract][Full Text] [Related]
4. Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.
de Mello RA; Ferreira M; Costa S; Costa BM; Pires FS; Neves I; Almeida MI; Cunha J; Oliveira P; Hespanhol V; Reis RM
Tumour Biol; 2012 Oct; 33(5):1341-8. PubMed ID: 22457050
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between EGF +61A>G polymorphism and melanoma susceptibility in Caucasians: a HuGE review and meta-analysis.
Wu D; Wu Y; Zhang X; Cong P; Lv X
Gene; 2013 Feb; 515(2):359-66. PubMed ID: 23201894
[TBL] [Abstract][Full Text] [Related]
6. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
7. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer.
Kang HG; Choi JE; Lee WK; Kam S; Cha SI; Kim CH; Jung TH; Park JY
Respirology; 2007 Nov; 12(6):902-5. PubMed ID: 17986122
[TBL] [Abstract][Full Text] [Related]
8. EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients.
Leal LF; Laus AC; Cavagna R; de Paula FE; de Oliveira MA; Ribeiro DM; Hassan FM; Miziara JE; da Silva ECA; da Silva VD; De Marchi P; Reis RM
Thorac Cancer; 2020 Oct; 11(10):2987-2992. PubMed ID: 32881389
[TBL] [Abstract][Full Text] [Related]
9. EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population.
Laus AC; de Paula FE; de Lima MA; Carlos CD; Gomes INF; de Marchi P; Valente JKN; Pioltini ABM; Miziara JE; da Silva CM; Viana LS; Scapulatempo-Neto C; Reis RM
Mol Biol Rep; 2019 Apr; 46(2):2417-2425. PubMed ID: 30783937
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between leptin G-2548A polymorphisms and obesity risk: Evidence based on a meta-analysis.
Yan J; Wang X; Tao H; Yang W; Luo M; Lin F
Obes Res Clin Pract; 2015; 9(4):389-97. PubMed ID: 25733497
[TBL] [Abstract][Full Text] [Related]
11. Association between EGF +61A/G polymorphism and gastric cancer in Caucasians.
Araújo AP; Costa BM; Pinto-Correia AL; Fragoso M; Ferreira P; Dinis-Ribeiro M; Costa S; Reis RM; Medeiros R
World J Gastroenterol; 2011 Jan; 17(4):488-92. PubMed ID: 21274378
[TBL] [Abstract][Full Text] [Related]
12. Clinical Implication of EGF A61G Polymorphism in the Risk of Non Small Cell Lung Adenocarcinoma Patients: A Case Control Study.
Masroor M; Amit J; Javid J; Mir R; Prasant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7529-34. PubMed ID: 26625757
[TBL] [Abstract][Full Text] [Related]
13. [The relationship between polymorphisms of epidermal growth factor gene and silicosis].
Jiang DP; Wang CY; Fan XY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Nov; 31(11):820-4. PubMed ID: 24370290
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of epidermal growth factor polymorphisms and cancer risk: involving 9,779 cases and 15,932 controls.
Li TF; Ren KW; Liu PF
DNA Cell Biol; 2012 Apr; 31(4):568-74. PubMed ID: 22070650
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis.
Yang Z; Wu Q; Shi Y; Nie Y; Wu K; Fan D
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1086-91. PubMed ID: 22852842
[TBL] [Abstract][Full Text] [Related]
16. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
17. Association between the risk of hepatitis virus-related hepatocellular carcinoma and EGF polymorphism: A PRISMA-compliant updated meta-analysis.
Wang Q; Xu L; Wu Q; Zhang M; Zhang J
Medicine (Baltimore); 2022 Oct; 101(42):e31280. PubMed ID: 36281156
[TBL] [Abstract][Full Text] [Related]
18. Association of transferrin G258A and transferrin receptor A82G polymorphisms with the risk of Parkinson disease in certain area.
Wang Y; Wang Y; Zhou M; Jiang D; Deng X
Medicine (Baltimore); 2020 Nov; 99(48):e23432. PubMed ID: 33235126
[TBL] [Abstract][Full Text] [Related]
19. Association of Epidermal Growth Factor 61A>G, Survivin -31G>C, and EFNA1 -1732G>A Polymorphisms with Susceptibility to Colorectal Cancer.
Asadian F; Ghadyani M; Antikchi MH; Dastgheib SA; Neamatzadeh H; Sheikhpour E; Khajehnoori S; Tabei SS
J Gastrointest Cancer; 2022 Mar; 53(1):78-83. PubMed ID: 33180239
[TBL] [Abstract][Full Text] [Related]
20. Genetic Association of ERCC6 rs2228526 Polymorphism with the Risk of Cancer: Evidence from a Meta-Analysis.
Lin X; Wu Y; Li Q; Yu H; Li X; Li X; Zheng J
Biomed Res Int; 2022; 2022():2662666. PubMed ID: 35463969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]